Literature DB >> 27381854

Longitudinal changes in cerebral blood flow velocities in different clinical courses of migraine.

Mi Ji Lee1, Min Kyung Chu2, Hanna Choi3, Hyun Ah Choi1, Chungbin Lee1, Chin-Sang Chung1.   

Abstract

Objective To assess longitudinal changes in cerebral blood flow velocities (ΔCBFVs) according to the clinical course of migraine. Methods We retrospectively included migraine patients with two or more attacks per month at baseline who were followed up within 2 years with transcranial Doppler in a tertiary headache clinic. ΔCBFVs were analyzed in relation to clinical courses, defined as remission (0-1 headache days/month), persistence (2-14/month), or progression (≥15/month) in episodic migraine (EM), and conversion to EM (<15/month) and persistence (≥15/month) in chronic migraine (CM). Results A total of 166 patients (90 EM and 76 CM) were included. In EM, the remission group ( n = 30) showed a decrease in CBFV in the middle cerebral artery (MCA) and the basilar artery (BA). The progression group ( n = 10) showed increasing CBFVs in the bilateral MCAs. Patients with the persistence course ( n = 50) showed generally unchanged CBFVs. In CM, ΔCBFVs decreased in the BA and increased in the posterior cerebral artery (PCA) after conversion to EM ( n = 61), whereas they remained unchanged in the persistence group ( n = 15). In all patients, % change in headache days was positively correlated with the %ΔCBFVs of the bilateral MCAs and the BA. Conclusions CBFV changes are associated with the different clinical courses of migraine. The association is more prominent in EM than CM.

Entities:  

Keywords:  Migraine; cerebral hemodynamics; prognosis; transcranial Doppler

Mesh:

Year:  2016        PMID: 27381854     DOI: 10.1177/0333102416658715

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine-A Real-Life Study.

Authors:  Magdalena Nowaczewska; Marcin Straburzyński; Marta Waliszewska-Prosół; Grzegorz Meder; Joanna Janiak-Kiszka; Wojciech Kaźmierczak
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

Review 2.  From transformation to chronification of migraine: pathophysiological and clinical aspects.

Authors:  M Torres-Ferrús; F Ursitti; A Alpuente; F Brunello; D Chiappino; T de Vries; S Di Marco; S Ferlisi; L Guerritore; N Gonzalez-Garcia; A Gonzalez-Martinez; D Khutorov; M Kritsilis; A Kyrou; T Makeeva; A Minguez-Olaondo; L Pilati; A Serrien; O Tsurkalenko; D Van den Abbeele; W S van Hoogstraten; C Lampl
Journal:  J Headache Pain       Date:  2020-04-29       Impact factor: 7.277

3.  Migraine Genetic Variants Influence Cerebral Blood Flow.

Authors:  Maria J Knol; Elizabeth A Loehrer; Ke-Xin Wen; Daniel Bos; M Kamran Ikram; Meike W Vernooij; Hieab H H Adams; M Arfan Ikram
Journal:  Headache       Date:  2019-09-26       Impact factor: 5.887

4.  Cerebrovascular function in tension-type headache and migraine with or without aura: Transcranial Doppler study.

Authors:  Eman M Khedr; Mohammed A Abbas; Ayman Gamea; Mohamed A Sadek; Ahmed F Zaki
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

5.  Low-frequency facial hemodynamic oscillations distinguish migraineurs from non-headache controls.

Authors:  Melissa M Cortez; Jeremy J Theriot; Natalie A Rea; Forrest E Gowen; K C Brennan
Journal:  Cephalalgia Rep       Date:  2019-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.